These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 4123433

  • 41. [Molecular defect in hemophilia and von Willebrand's disease (author's transl)].
    Fukui H.
    Rinsho Byori; 1976 Apr; 24(4):274-8. PubMed ID: 1084430
    [No Abstract] [Full Text] [Related]

  • 42. [Immune coagulation disorders (excluding antiphospholipid syndrome].
    Arai M.
    Rinsho Byori; 2001 Oct; 49(10):1000-4. PubMed ID: 11769464
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Studies on the nature of antihemophilic factor (factor VIII). Further evidence relating the AHF-like antigens in normal and hemophilic plasmas.
    Bennett B, Forman WB, Ratnoff OD.
    J Clin Invest; 1973 Sep; 52(9):2191-7. PubMed ID: 4199413
    [Abstract] [Full Text] [Related]

  • 45. A simple enzyme-immunoassay (EIA) test for factor VIII-related antigen (VIIIAGN).
    Ness PM, Perkins HA.
    Thromb Haemost; 1979 Oct 31; 42(3):848-54. PubMed ID: 116386
    [Abstract] [Full Text] [Related]

  • 46. Implications of immunologic methods for measuring antihemophilic factor (factor VIII).
    Hoyer LW, Rick ME.
    Ann N Y Acad Sci; 1975 Jan 20; 240():97-108. PubMed ID: 46140
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. The defect in hemophilic and von Willebrand's disease plasmas studied by a recombination technique.
    Cooper HA, Wagner RH.
    J Clin Invest; 1974 Nov 20; 54(5):1093-9. PubMed ID: 4213756
    [Abstract] [Full Text] [Related]

  • 49. Antigen-biological-activity ratio for factor VIII.
    Hougie C, Sargeant R.
    Lancet; 1973 Mar 17; 1(7803):616-7. PubMed ID: 4120690
    [No Abstract] [Full Text] [Related]

  • 50. Recent advances in hemophilia. Part II. Genetics. Chairman's introductory remarks: Detection of the carrier state of classic hemophilia.
    Ratnoff OD, Steinberg AG.
    Ann N Y Acad Sci; 1975 Jan 20; 240():95-6. PubMed ID: 1078624
    [No Abstract] [Full Text] [Related]

  • 51. Factor VIII-related antigen (VIII R:AG) in haemophilic patients and in carriers.
    Bowie EJ, Fass DN.
    Lancet; 1979 Nov 17; 2(8151):1049-50. PubMed ID: 91786
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Immune status of HIV and HCV negative haemophiliacs treated with intermediate-purity factor VIII concentrates.
    Funk M, Ebener U, Kreuz W, Ehrenforth S.
    Lancet; 1993 Oct 09; 342(8876):933-4. PubMed ID: 7692198
    [No Abstract] [Full Text] [Related]

  • 55. Medical staff conference: recent chapters in the factor VIII saga--perils of a protein. Fifth annual Paul M. Aggeler Memorial Lecture.
    West J Med; 1975 May 09; 122(5):406-16. PubMed ID: 1079388
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.